Heart-Forever
Latest round
- Series A
Last raised
- May 2024
Total raised
- Undisclosed
Investors
- 2
About Heart-Forever
Established in 2020 and based in Beijing, China, Heart-Forever operates as a cardiovascular and cerebrovascular disease diagnosis and treatment service provider dedicated to providing blood pressure monitoring products. It has a sub-branch office in Tianjin. The co-founder of the company, Yibin Li graduated from Tsinghua University and has research experience in blood pressure monitoring. The co-founder of the company, Yaoguang Wei graduated from the University of Minnesota and has experience in chip design and artificial intelligence. The company has obtained 6 patents. The company mainly provides blood pressure monitoring equipment and blood pressure monitoring solutions through its pressure sensor, blood pressure calculation module and continuous blood pressure monitoring algorithm technology. The blood pressure monitoring equipment can be used to detect blood pressure, heart rate, blood oxygen, electrocardiogram, and sleep detection. It has functions such as non-inflated blood pressure measurement, continuous blood pressure monitoring, abnormal blood pressure reminder, etc. Heart-Forever also provides supporting application, which can provides blood pressure report. The products are mainly aimed at hypertension and cardiovascular and cerebrovascular diseases. The company generates revenue by providing blood pressure monitoring equipment and blood pressure monitoring solutions.
Who invested in Heart-Forever
2 investors across 2 rounds
See all investors in Heart-Forever
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Heart-Forever
Who invested in Heart-Forever?
Heart-Forever has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Heart-Forever raised?
Heart-Forever has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Heart-Forever last raise money?
Heart-Forever's most recent round on record is a Series A, in May 2024.
What does Heart-Forever do?
Established in 2020 and based in Beijing, China, Heart-Forever operates as a cardiovascular and cerebrovascular disease diagnosis and treatment service provider dedicated to providing blood pressure monitoring products.
Where is Heart-Forever headquartered?
Heart-Forever is headquartered in Beijing, China.
Which VCs invest in companies like Heart-Forever?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Heart-Forever's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Heart-Forever? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.